跳至主要内容
临床试验/NCT05234125
NCT05234125招募中不适用

A Randomized Control Trial to Improve Metabolic Outcomes in African American Pregnant Women

University of Illinois at Chicago3 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2022年8月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
3
主要终点
Fasting Glucose

研究概览

简要总结

The purpose of this randomized controlled trial is to establish the effectiveness of a culturally targeted and individually tailored behavioral intervention to promote maternal glucose metabolism in African American women.

详细描述

This is a randomized controlled parallel-group trial with two arms. Potential subjects will be identified from the OB Clinics at UI health systems, the University of Illinois at Chicago. After baseline assessments, the subjects will be randomized to the attention control arm (Birth-Prep) or BETTER intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • African American pregnant woman.
  • Women between 16 and 22 GWs.
  • Overweight or obese - pregravid Body Mass Index >25.0 kg/m
  • Singleton gestation.
  • Established prenatal care at The University of Illinois Hospital & Health Sciences.
  • System Obstetric (UIHHSS' OB) clinics. Able to understand, speak and write in English.

排除标准

  • Multiple gestations.
  • Night-shift work.
  • Diagnosed sleep disorders.
  • Known fetal chromosomal or anatomical abnormalities.
  • Diagnosed mood disorders.
  • Gestational diabetes in early pregnancy.
  • Glycated Hemoglobin (HbA1c) ≥ 6.5%.
  • Hypoglycemic medications.
  • Stimulant medication or taking a sleeping aid.
  • Active drug abuse/excessive alcohol intake.

研究组 & 干预措施

Intervention arm

Active Comparator

Sleep hygiene practices and cognitive-behavioral principles

干预措施: Better (Behavioral)

Attention control

Placebo Comparator

Training about pregnancy issues

干预措施: Birth Prep (Behavioral)

结局指标

主要结局

Fasting Glucose

时间窗: 28-32 Gestational Weeks (GWs)

A fasting blood sample for glucose will be collected

Fasting Glucose at baseline

时间窗: 16-22 Gestational Weeks (GWs)

A fasting blood sample for glucose will be collected

次要结局

  • Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) at baseline(16-22 Gestational Weeks)
  • Glucose Area Under the Curve at baseline(16-22 Gestational Weeks)
  • Sleep Quality - Self-reported of sleep quality at the baseline "before the intervention"(16-22 Gestational Weeks)
  • Sleep Quality - Self-reported of sleep quality(34-36 Gestational Weeks)
  • Glucose Area Under the Curve(34-36 Gestational Weeks)
  • Sleep duration and sleep timing - Subjective and Objective Assessment(34-36 Gestational Weeks)
  • Medical Records Extraction Form("post delivery, up to 3 months post intervention")
  • Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)(28-32 Gestational Weeks)
  • Sleep duration and sleep timing - Subjectively and Objectively Assessment at the baseline "before the intervention"(16-22 Gestational Weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bilgay Izci Balserak

Associate Professor

University of Illinois at Chicago

研究点 (3)

Loading locations...

相似试验